Pulmonary Ventilation
Conditions
Interventions
This is a prospective, descriptive, and longitudinal clinical trial study. Volunteers will be divided into 2 groups (15 individuals each), randomly assigned according to patient demand and hospitaliza
s clinical condition, during 7 sessions, and conventional treatment with antibiotic therapy associated with respiratory physiotherapy through specific bronchial hygiene maneuvers (vibration and vibroc
s respiratory capacity will be measured through the strength of the respiratory muscles using Pimax and Pemax
Sponsors
Centro Universitário de Itajubá
Centro Universitário de Itajubá
Eligibility
Age
55 Years to 85 Years
Inclusion criteria
Inclusion criteria: Participants aged 55-85 years; with a clinical diagnosis of community-acquired pneumonia (Streptococcus pneumoniae); undergoing conventional respiratory physiotherapy treatment; on oxygen therapy up to 1 L/minO2 and on antibiotic therapy (azalides, cephalosporins, fluoroquinolones); both sexes
Exclusion criteria
Exclusion criteria: Patients diagnosed with fungal and viral pneumonia; with hospital-acquired pneumonia (those hospitalized for more than 2 days in the previous 90 days); institutionalized; overweight (Body Mass Index – BMI: above 29.9 kg/m2); who do not sign the Informed Consent Form; who do not belong to the stated age range; who have neoplasms and a history of photosensitivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: Improvement in the infectious condition and consequent pulmonary function, with a reduction in hospital stay time in patients using infrared LED photobiomodulation. ;Finding outcome 1: Improvement in the infectious condition, clinical condition, and pulmonary function, with a reduction in hospital stay time in patients using infrared LED photobiomodulation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected Outcome 2: Improvement in ventilatory mechanics, respiratory muscle strength, and the patient's clinical condition (respiratory repercussions, pulmonary auscultation, and pulse oximetry) is expected after the use of infrared LED photobiomodulation;Finding Outcome 2: There was an improvement in the pulmonary recovery process and clinical picture, a reduction in respiratory symptoms, a decrease in hospital stay time (9.3 vs. 7.3 days) (p<0.001), an increase in peripheral oxygen saturation (SpO2) (88.3 to 98%), in maximum inspiratory pressure (MIP) (-40 to -65.3 cmH2O), in forced vital capacity (FVC) (62% to 80%) (p<0.001), and an improvement in hematological data, such as erythrocytes (3.51 to 5.54 mm³), typical lymphocytes (40 to 31%), and hemoglobin (12.3 to 14.6 mg/dL) (p<0.05), as well as in pulmonary auscultation (6.1 to 3.1 days) (p<0.001). It is considered a relevant adjuvant treatment with conventional therapy, as it improved the pulmonary and clinical status of patients, reduced respiratory symptoms, and decreased the length of hospital stay | — |
Countries
Brazil
Contacts
Public ContactPâmela Pereira
Centro Universitário de Itajubá
Outcome results
None listed